Connect with us

Business

Elevation Point Wealth Partners Reduces Oracle Holdings by 35.4%

editorial

Published

on

Elevation Point Wealth Partners LLC has significantly reduced its stake in Oracle Corporation, selling 6,030 shares during the second quarter of 2023. This decision results in a 35.4% decrease in their holdings, leaving the institutional investor with 11,010 shares valued at approximately $2.4 million as of the end of June 2023. The details of this transaction were disclosed in a recent filing with the Securities and Exchange Commission (SEC).

A series of other institutional investors have also adjusted their positions in Oracle recently. Notably, Nuveen LLC acquired a new stake valued at $732.7 million during the first quarter. Vanguard Group Inc. increased its holdings by 2.2%, now owning over 160.9 million shares worth approximately $22.5 billion after purchasing an additional 3.5 million shares. Meanwhile, Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake by an impressive 79.2%, acquiring nearly 2.1 million shares, now valued at around $648.6 million.

In total, around 42.44% of Oracle’s stock is currently owned by institutional investors and hedge funds, reflecting significant institutional interest in the company.

Market Analysts’ Perspectives

Several research analysts have recently evaluated Oracle’s stock performance. Sanford C. Bernstein raised their target price from $363.00 to $364.00, maintaining an “outperform” rating. Morgan Stanley also increased their price objective from $246.00 to $320.00, assigning an “equal weight” rating. Meanwhile, Royal Bank of Canada reiterated a “sector perform” rating with a target price of $310.00.

In contrast, Rothschild & Co Redburn initiated coverage with a “sell” rating and a target of $175.00. Overall, the consensus among analysts indicates a “Moderate Buy” rating, with an average price target of $324.89.

Oracle’s Stock Performance and Financial Health

As of October 23, 2023, shares of Oracle Corporation (NYSE: ORCL) opened at $205.29. The company has a market capitalization of $585.2 billion and reported a P/E ratio of 47.52. Oracle’s stock has fluctuated significantly over the past year, with a low of $118.86 and a high of $345.72.

On September 9, 2023, Oracle announced its quarterly earnings, reporting an EPS of $1.47, which fell slightly short of analysts’ expectations at $1.48. The company generated $14.93 billion in revenue, missing the forecast of $15.04 billion. Despite this, Oracle reported a year-on-year revenue increase of 12.2%.

Oracle has provided guidance for Q2 2026, estimating an EPS between $1.270 and $1.310. Analysts are projecting a total of $5 in earnings per share for the current fiscal year.

In addition, the company has declared a quarterly dividend of $0.50 per share, which was paid on October 23, 2023. This dividend represents an annualized payout of $2.00 and a yield of 1.0%. The current payout ratio stands at 46.3%.

Recent insider trading activity has also drawn attention, with Stuart Levey, Executive Vice President, selling 19,758 shares at an average price of $300.00, totaling $5.93 million. Following this transaction, Levey holds 18,429 shares valued at approximately $5.53 million. Similarly, Michael D. Sicilia sold 33,845 shares at about $321.16, worth around $10.87 million.

In total, corporate insiders have sold over 204,254 shares valued at approximately $60.2 million in the past 90 days, with insiders currently holding 40.9% of Oracle’s stock.

As Oracle continues to adapt to the evolving technology landscape, the institutional interest and analysts’ evaluations suggest a complex but optimistic outlook for the enterprise software giant.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.